A Phase 1 Study Of Tti-621, A Novel Immune Checkpoint Inhibitor Targeting Cd47, In Patients With Relapsed Or Refractory Hematologic MalignanciesStephen M. Ansell,Robert Chen,Ian W. Flinn,Michael B. Maris,Owen A. O'Connor,Lisa D. Johnson,Meghan Irwin,Penka S. Petrova,Robert A. Uger,Eric L. SieversBLOOD(2016)引用 31|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要